key: cord-0775249-97nl1riw
authors: Scharf, C.; Di Brizzi, E.V.; Pellerone, S.; Liguori, M.; Giorgio, C.M.R.; Argenziano, G.
title: Nevocentric erythema multiforme after SARS‐COV‐2 vaccine
date: 2021-09-30
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.17688
sha: e43680288f9cd0e564e3200870d2d6a660ea7bf1
doc_id: 775249
cord_uid: 97nl1riw

A 27-year-old woman presented to our Dermatology Unit referring an acute skin rash with no associated systemic symptoms. Three days before, the patient had taken the SARS-COV-2 vaccine (Comirnaty™ - BioNTech/Pfizer). Physical examination showed erythematous, ring-shaped plaques only surrounding several, but not all of her melanocytic nevi.

was made. Therapy with cetirizine 10 mg and moisturizers was initiated with complete resolution seen after 2 weeks. At the follow-up examination, no changes were found in her otherwise banal pre-existing nevi.

Most cases of nevocentric EM reported in the literature were described as a postherpetic phenomenon. 1 McKenna 2 and Pariser 3 reported two adult female patients with nevocentric EM affecting the trunk and limbs after a HSV infection of the lower lip. Mons alvez et al. 4 described the case of a pregnant woman, with history of recurrent labial herpes, presenting with halos of erythema around her nevi. Finally, Di Brizzi et al. 1 reported a case of a 9-year-old girl presenting a nevocentric EM after labial herpes. The only case non-related to a herpetic infection was described by Humphreys and Cox 5 occurring in a 37-year-old female patient after the ingestion of thiabendazone. The reaction itself differs from the well-known phenomenon described by Meyerson 6 in 1971, which consists of an eczematous halo surrounding a pre-existing melanocytic nevus, but it is not clear whether an interaction between CD4 T lymphocytes and increased expression of intercellular cell adhesion molecule 1 might be involved in both these nevocentric processes. 7 The course of nevocentric EM does not differ from the classical form of EM, and no alterations of the affected nevi were reported previously. Along these lines, patients can be reassured of the benign outcome of this condition.

Albeit the pathogenesis of EM 'targeting' nevi is obscure, in our case, we can hypothesize a similar mechanism as that involved in post-HSV nevocentric EM. The specific vaccine used in our patient was a modified messenger RNA in lipidic nanoparticles that allows the liberation of a non-replicant RNA inside the host cells, expressing the 'S' SARS-COV-2 antigen transitorily. It is therefore plausible that the vaccine may induce a similar reaction to that occurring after an HSV infection.

In conclusion, nevocentric EM is a benign, limited condition that can be added to the list of possible skin reactions associated with SARS-COV-2 vaccines.

Nevocentric erythema multiforme in a child

Naevocentric erythema multiforme associated with herpes labialis

Nevocentric erythema multiforme

Eritema exudativo multiforme perin evico

Thiabendazole-induced erythema multiform with lesions around melanocytic naevi

A peculiar papulosquamous eruption involving pigmented nevi

Meyerson phenomenon

Figure 2 Clinical images showing the purpuric ring around the nevi. (a) Dermoscopically, a typical globular nevus is surrounded by a pinkish halo that becomes more prominent at the periphery (b)

The patient in this manuscript has given written informed consent to the publication of her case details.

None.

Data sharing not applicable to this article as no datasets were generated or analysed during the current study